Development of a TMErisk model based on immune infiltration in tumour microenvironment to predict prognosis of immune checkpoint inhibitor treatment in hepatocellular carcinoma

Immune checkpoint inhibitor (ICI) treatment has created the opportunity of improved outcome for patients with hepatocellular carcinoma (HCC). However, only a minority of HCC patients benefit from ICI treatment owing to poor treatment efficacy and safety concerns. There are few predictive factors tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zi-Jun, Yu, Chu-Ting, Chen, Lei, Wang, Hong-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025430/
https://www.ncbi.nlm.nih.gov/pubmed/36882021
http://dx.doi.org/10.1093/bib/bbad067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025430/
https://www.ncbi.nlm.nih.gov/pubmed/36882021
http://dx.doi.org/10.1093/bib/bbad067

Ejemplares similares